Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Gas6 Deficiency Increases Oligodendrocyte Loss and Microglial Activation in Response to Cuprizone-Induced Demyelination
Michele D. Binder, Holly S. Cate, Anne L. Prieto, Dennis Kemper, Helmut Butzkueven, Melissa Gresle, Tania Cipriani, Vilija Jokubaitis, Peter Carmeliet, Trevor J. Kilpatrick (2008). Gas6 Deficiency Increases Oligodendrocyte Loss and Microglial Activation in Response to Cuprizone-Induced Demyelination. , 28(20), DOI: https://doi.org/10.1523/jneurosci.1180-08.2008.
Article183 days agoDiagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria
Xavier Montalbán, Christine Lebrun‐Frénay, Jiwon Oh, Georgina Arrambide, Marcello Moccia, Maria Pia Amato, Lilyana Amezcua, Brenda Banwell, Amit Bar-Or, Frederik Barkhof, Helmut Butzkueven, Olga Ciccarelli, Jeremy Chataway, Jeffrey A. Cohen, Giancarlo Comi, Jorge Correale, Florian Deisenhammer, Massimo Filippi, Julie Fiol, Mark S. Freedman, Kazuo Fujihara, Cristina Granziera, Ari Green, Hans-Peter Hartung, Kerstin Hellwig, L Kappos, Dorlan Kimbrough, Joep Killestein, Fred Lublin, Romain Marignier, Ruth Ann Marrie, Aaron Miller, Susana Otero-Romero, Daniel Ontaneda, Sudarshini Ramanathan, Daniel Reich, Maria A. Rocca, Àlex Rovira, Shiv Saidha, Amber Salter, Jaume Sastre‐Garriga, Deanna Saylor, Andrew Solomon, Maria Pia Sormani, Bruno Stankoff, Mar Tintoré, Helen Tremlett, Anneke van der Walt, Shanthi Viswanathan, Heinz Wiendl, Brigitte Wildemann, Bassem Yamout, Paola Zaratin, Peter A. Calabresi, Timothy Coetzee, Alan J. Thompson (2025). Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. , 24(10), DOI: https://doi.org/10.1016/s1474-4422(25)00270-4.
Article49 days agoDisease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries
Sifat Sharmin, Izanne Roos, Charles B. Malpas, Pietro Iaffaldano, Marta Simone, Massimo Filippi, Eva Havrdová, Serkan Özakbaş, Vincenzo Brescia Morra, Raed Alroughani, Mauro Zaffaroni, Francesco Patti, Sara Eichau, Giuseppe Salemi, Alessia Di Sapio, Matilde Inglese, Emilio Portaccio, María Trojano, Maria Pia Amato, Tomáš Kalinčík, Dana Horáková, Alexandre Prat, Marc Girard, Pierre Duquette, Cavit Boz, Carlo Pozzilli, Eleonora Cocco, Paolo Gallo, Bassem Yamout, Samia J. Khoury, Alessandra Lugaresi, Marco Onofrj, Giacomo Lus, Valentina Torri Clerici, Giorgia Teresa Maniscalco, Silvia Romano, Carla Tortorella, Paola Valentino, Marco Rovaris, Vahid Shaygannejad, Diana Ferraro, Marika Vianello, Pierre Grammond, Roberto Bergamaschi, Antonio Gallo, Paola Cavalla, María José Sá, Jeannette Lechner‐Scott, Ilaria Pesci, Katherine Buzzard, Riadh Gouider, Saloua Mrabet, Umberto Aguglia, Antonella Conte, Carlo Avolio, Paolo Bellantonio, Nevin John, Elisabetta Cartechini, Francesca De Robertis, Elisabetta Ferraro, Bianca Weinstock‐Guttman, Valeria Barcella, Anneke van der Walt, Helmut Butzkueven, Maria Gabriella Coniglio, Franco Granella, Jens Kühle, Girolama Alessandra Marfia, Guy Laureys, Liesbeth Van Hijfte, Davide Maimone, Paola Gazzola, Yolanda Blanco, Recai Türkoğlu, Sara Montepietra, Daniele Spitaleri, Vincent Van Pesch, Oliver Gerlach, Julie Prévost, Radek Ampapa, Aysun Soysal, Ayşe Altıntaş, Augusto Rini, Claudio Solaro, Alessandra Protti, Matteo Foschi, Andrea Surcinelli, Maurizia Gatto, Nerina Mascoli, Milena De Riz, Sabrina Realmuto, P. Rossi, Rocco Totaro, Michael Barnett, Jiwon Oh, Davide Nasuelli, Cristina Ramo‐Tello, José Luis Sánchez-Menoyo, Talal Al‐Harbi, Cristina Fioretti (2024). Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries. , 8(5), DOI: https://doi.org/10.1016/s2352-4642(24)00047-6.
Article49 days ago086 The rapid efficacy of natalizumab vs fingolimod in patients with active relapsing-remitting multiple sclerosis (RRMS): results from reveal, a randomised, head-to-head study
Helmut Butzkueven, Douglas Jeffery, Douglas L. Arnold, Massimo Filippi, Jeroen J.G. Geurts, Qunming Dong, Nolan Campbell, Stephanie Licata, Pei‐Ran Ho (2018). 086 The rapid efficacy of natalizumab vs fingolimod in patients with active relapsing-remitting multiple sclerosis (RRMS): results from reveal, a randomised, head-to-head study. , 89(6), DOI: https://doi.org/10.1136/jnnp-2018-anzan.85.
Article49 days agoNatalizumab vs fingolimod in patients with active relapsing-remitting multiple sclerosis (RRMS): comparative MRI assessments of disease activity from reveal, a randomized, head-to-head phase 4 study
Stephanie Licata, Helmut Butzkueven, Douglas Jeffery, Douglas L. Arnold, Massimo Filippi, Jeroen J.G. Geurts, Q. Dong, Nolan Campbell, Pei‐Ran Ho (2017). Natalizumab vs fingolimod in patients with active relapsing-remitting multiple sclerosis (RRMS): comparative MRI assessments of disease activity from reveal, a randomized, head-to-head phase 4 study. , 381, DOI: https://doi.org/10.1016/j.jns.2017.08.703.
Article49 days ago